APS Biocontrol

APS Biocontrol

Private
DundeeHealthcare & Life Scienceshttps://www.apsbiocontrol.com/

Last Round

Grant

Sep 1, 2021

Total Funding Raised

$1.4M

Company Overview

APS Biocontrol is a biotechnology company that develops and offers bacteriophage-based technologies as environmentally-sustainable replacements for synthetic chemicals in the agricultural and food processing sectors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clean Manufacturing, Waste Management

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

bacteriophage technologybiocontrolphage technologyfood spoilage preventionagri-biotechbiopesticidesagtechnatural antimicrobialspost-harvest treatmentfood safetypotato disease controlcustom phage developmentinsect repellent

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

APS Biocontrol Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

APS Biocontrol Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantSep 1, 2021
GrantJul 1, 2020
GrantMay 17, 2020
GrantMay 1, 2020
GrantMay 1, 2018
Grant
May 26, 2015

Key People

Founding team and executive leadership

Alison Blackwell

CEO

Executive Team

APS Biocontrol Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 3, 2025

    Increased 90% MoM, reaching 133 monthly visitors.

  • Dec 15, 2024

    Monthly visitors grew 442% MoM, reaching 997.

APS Biocontrol Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

APS Biocontrol Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about APS Biocontrol's valuation, stock price, and market status.

Firmographic Details

HeadquartersDundee
Employee Range6
Year Founded2004
Last FundingSep 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.